MARKET

MBX

MBX

MBX Biosciences Inc
NASDAQ
9.51
+0.52
+5.78%
Opening 11:26 04/24 EDT
OPEN
8.99
PREV CLOSE
8.99
HIGH
9.78
LOW
8.92
VOLUME
70.83K
TURNOVER
--
52 WEEK HIGH
27.50
52 WEEK LOW
4.807
MARKET CAP
317.87M
P/E (TTM)
-1.6346
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MBX last week (0414-0418)?
Weekly Report · 3d ago
Ascendis Pharma initiated with an Outperform at RBC Capital
TipRanks · 04/15 20:50
Weekly Report: what happened at MBX last week (0407-0411)?
Weekly Report · 04/14 12:34
Director Makes Bold Move with Major MBX Biosciences Stock Purchase
TipRanks · 04/11 02:02
MBX Biosciences initiated at Market Outperform by Citizens
Seeking Alpha · 04/10 17:38
MBX Biosciences Initiated at Market Outperform by JMP Securities
Dow Jones · 04/10 13:53
MBX Biosciences Price Target Announced at $38.00/Share by JMP Securities
Dow Jones · 04/10 13:53
JMP Securities Initiates Coverage On MBX Biosciences with Market Outperform Rating, Announces Price Target of $38
Benzinga · 04/10 13:42
More
About MBX
More
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. It has built its proprietary Precision Endocrine Peptide platform to develop precision peptide therapies that are designed to overcome key limitations of current peptide therapies. Its product candidates and programs include MBX 2109, MBX 1416 and Obesity portfolio. MBX 2109 is a parathyroid hormone peptide prodrug that is designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. MBX 1416 is designed to be a long-acting glucagon-like peptide-1 (GLP-1), receptor antagonist, as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. MBX 4291 is designed to be a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide, receptor co-agonist prodrug.
Recently
Symbol
Price
%Change

Webull offers MBX Biosciences, Inc. stock information, including NASDAQ: MBX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MBX stock methods without spending real money on the virtual paper trading platform.